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Abstract 
Signal transduction through G protein-coupled receptors (GPCRs) involves 
binding to signalling molecules at the cell surface, which leads to global changes 
in molecular conformation that are communicated through the membrane. 
Artificial mechanisms for communication involving ligand binding and global 
conformational switching have been demonstrated so far only in the solution 
phase. Here we report a membrane-bound synthetic receptor that responds to 
binding of a ligand by undergoing a conformational change that is propagated 
over several nanometres, deep into the phospholipid bilayer. Our design uses a 
helical foldamer core, with structural features borrowed from a class of 
membrane-active fungal antibiotics, ligated to a water-compatible, metal-centred 
binding site and a conformationally-responsive fluorophore. Using the 
fluorophore as a remote reporter of conformational change, we find that binding 
of specific carboxylate ligands to a Cu(II) cofactor at the binding site perturbs the 
foldamer's global conformation, mimicking the conformational response of a 
GPCR to ligand binding.   
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Controlling the transmission of biochemical information across phospholipid 
bilayers is an enormous opportunity in synthetic biology. Artificial signal 
transduction would allow orthogonal signalling pathways to be introduced into 
cells, “short-circuiting” their signalling networks, or would facilitate 
communication between compartments1 in artificial tissues.2 Cellular signal 
transduction is largely mediated by three classes of membrane proteins: tyrosine 
kinase receptors, ligand-gated channels and (most abundantly) G protein-
coupled receptors (GPCRs). Efforts have been made to replicate the mode of 
action of first two,3-6 but mimics of GPCRs, which offer the greatest scope for use 
in synthetic biology, have proved elusive. While many structural details of GPCR-
mediated signal transduction are poorly understood,7 a general mechanism is 
clear.8,9 GPCRs, which comprise seven transmembrane helices, adopt a number 
of interchanging conformational states in the membrane.10,11 Selective binding of 
an appropriate signalling ligand at a site exposed to the extracellular medium 
induces a local conformational preference in the tertiary structure of a receptor, 
which propagates through the GPCR and across the bilayer to the cytosolic 
terminus >4 nm distant.12 This new conformational state, which predominates 
over the others, initiates the signalling cascade. Synthetic molecules have been 
designed that have functional analogy with ligand-activated GPCRs like the β2 
adrenoreceptor,1 but they work only in organic solvents.13-16 
Results and Discussion 
Design of the receptor mimic. We set out to design and construct a synthetic 
molecular structure exhibiting the 'minimal' essential design features required 
for a functional mimic of a ligand-activated GPCR. The key aspects of the design 
are shown in Fig. 1. It has the following features: (i) a hydrophobic scaffold (Fig. 
1b, shown in grey) that inserts into a phospholipid bilayer and has molecular 
dimensions commensurate with bilayer width; (ii) two interconverting 
conformational states that are perturbed by binding of a chiral ligand to a 
binding site; (iii) a binding pocket (Fig. 1b, green) with a metal(II) ion cofactor 
that allows strong, reversible, and shape-selective binding of aqueous ligands 
(Fig. 1b, red) at the bilayer interface, even in the presence of water; (iv) a remote 
group that gives a detectable spectroscopic response to changes in 
conformational state (Fig. 1b, blue). 
As the molecular scaffold forming the core of the receptor, we chose a 
structural motif characteristic of peptaibols,17 fungal antibiotics that insert into 
and permeabilise membranes. Peptaibols are rich in the quaternary amino acid 
α-aminoisobutyric acid (Aib), which induces them to fold into helical 
conformations with hydrophobic character. Synthetic oligomers built solely from 
Aib fold into 310 helices (Figure 1a, “Relay”),18 with decamers being sufficiently 
long to span a bilayer.19 In solution, these “foldamers”20 populate almost 
exclusively21 two rapidly exchanging conformational states of left or right 
handed helical screw sense, with the relative population of these two states 
being remarkably sensitive to chiral influences.22-25 A chiral ligand covalently15 
or non-covalently16 bound to one terminus of an Aib foldamer will propagate its 
conformational influence through the entire foldamer length.26 In this way end-
to-end transmission of binding information over multi-nanometre distances has 
been accomplished through Aib foldamers dissolved in organic solvents.15,27,28 
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Recently, covalently controlled conformational switching over multi-nanometre 
distances within membrane-bound Aib foldamers was demonstrated using a 
light-switchable molecule.29 
The ligand binding pocket was constructed from a cationic metal(II) 
bis(2-quinolylmethyl)(2-pyridylmethyl)amine (BQPA) complex (Fig. 1a, 
“Input”).30 Complexation of a chiral guest (such as a carboxylate, Fig. 2a) in 
acetonitrile induces the achiral BQPA-metal complex to adopt preferentially one 
of two mirror-image (M or P) propeller-shaped conformations.31 To validate 
foldamer-linked Cu-BQPA as a conformationally responsive binding site, 
incremental amounts of enantiomeric ligands Boc-L-Pro (L-2a) or Boc-D-Pro (D-
2a) in CH3CN were added to Cu-3 bearing an N-terminal copper(II) BQPA 
complex (Supplementary Fig. 4.11). Equal and opposite changes in the Cotton 
effect at 239 nm were observed, confirming tight binding (Kd < 1 μM) of these 
prototypical chiral ligands to the metal ion and induction of chirality in the BQPA 
binding pocket (Fig. 2f). 
Pyrene fluorescence was used to detect the conformational response of 
the receptor mimic when embedded in a vesicle membrane. Other analytical 
techniques typically used for conformational analysis of foldamers in solution14-
16 were found to be ill-suited to the membrane phase and/or Cu(II) ions. Pyrene 
has a monomer fluorescence emission at 378 nm, and depending on their 
proximity and relative orientation, a pair of pyrene fluorophores may form an 
excimer that emits at 450 nm.13 A ratiometric fluorescent probe of conformation 
was synthesised (Fig. 1a, “Output”) by incorporating two pyrene units into a 
chiral diamine, which was ligated to the terminus of an Aib oligomer. The two 
helical screw-sense conformations of the Aib foldamer were expected to induce 
diastereoisomeric conformations in the fluorophore (Figure 1b, in blue), each 
with a characteristic ratio of excimer to monomer emission (E/M ratio). 
Fluorescence spectroscopy of a series of Aib foldamers bearing covalently linked 
N-terminal chiral residues showed a clear dependence of the E/M ratio on the 
ratio of screw-sense populations in solution (see Supplementary Fig. 4.10), with 
an increase in the proportion of P helix causing an increase in E/M. 
Function of the receptor mimic in solution. The synthesis of receptor 1 builds 
a structure that has these three components - a binding site, a signal relay and a 
fluorescent reporter (Fig. 1). After adding the copper(II) cofactor, the resulting 
complex Cu-1 was treated with a pair of enantiomeric carboxylates in 
acetonitrile solution (Fig. 2a,b). Adding incremental amounts of Boc-L-Pro (L-2a) 
and Boc-D-Pro (D-2a) in CH3CN caused changes in both the CD and fluorescence 
spectra (Fig. 2c-e) not seen in a control Aib foldamer 4 lacking the Cu(BQPA) 
binding pocket (Fig. 2g and Supplementary Fig. 4.11). Crucially, the enantiomers 
L-2a and D-2a gave opposite responses; L-2a induced positive ellipticity at 239 
nm, an increase in excimer emission and an increase in E/M ratio (from 1.65 to 
1.82), whereas D-2a induced negative ellipticity, a decrease in excimer emission 
and a decrease in E/M (from 1.65 to 1.42). These parallel spectral changes 
indicate firstly that a local chiral preference is induced in the BQPA binding site 
(giving rise to the Cotton effect at 239 nm), and secondly that the conformational 
preference is transmitted through the helical oligomer to the remote C-terminal 
fluorophore (inducing a change in excimer fluorescence that produces a change 
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in E/M ratio). Analysis of the CD and excimer emission data using a 1:1 binding 
model showed tight binding to 1 in CH3CN, providing Kd = 1 µM for D-2a and Kd = 
1.7 µM for L-2a.  
Function of the receptor mimic in the membrane. With the receptor mimic 
Cu-1 functioning in an organic solvent, we explored its behaviour in the 
membrane phase. Vesicles were made from the phospholipid 1,2-dioleoyl-sn-
glycero-3-phosphocholine (DOPC), which at 25 °C gives fluid bilayers32 that 
allowed Cu-1 the conformational freedom to respond to ligand binding. DOPC 
bilayers also have a hydrophobic thickness of 2.88 nm32 commensurate with the 
2.6 nm estimated hydrophobic length of Cu-1. An aliquot of Cu-1 in acetonitrile 
was added to a suspension of large unilamellar vesicles (LUVs, 800 nm diameter, 
at pH 7.4) to give vesicles with 0.4 mol% Cu-1, a low loading that minimised 
inter-receptor contacts. A rapid >100-fold increase in fluorescence occurred (Fig. 
3b,c), consistent with insertion of a pyrene moiety into a bilayer.33 This increase 
in emission stabilised after 25 minutes, leading to steady value of E/M = 1.25 
(Fig. 3c). A similar value for E/M was found for membrane loadings from 0.2 to 1 
mol% (Supplementary Fig. 6.3), suggesting that at these loadings intermolecular 
excimer formation due to aggregation is not significant. Incorporation of Cu-1 
into bilayers was confirmed by fluorescence microscopy (Fig. 3d), which showed 
pyrene excimer fluorescence localised in the LUVs. The fluorescence emission 
from Cu-1 in buffer alone was much weaker than the emission from membrane-
embedded Cu-1 (see Supplementary Information Section 6.5.1), allowing the 
effect of any non-inserted Cu-1 to be disregarded. 
The conformational responsiveness of membrane-bound Cu-1 was explored by 
adding carboxylate ligands to the suspension of vesicles. As in isotropic solution, 
the addition of chiral ligands L-2a and D-2a (Fig. 4a) to Cu-1 in a bilayer 
produced changes in its fluorescence spectrum, although much higher 
concentrations of ligand (100 times greater) were required to achieve a similar 
level of response. Intriguingly the membrane environment reversed the 
conformational response of the pyrene probe, indicating that an increase in E/M 
now corresponds to an increase in the proportion of M helix. This reversal of 
fluorescent response also occurred for covalently controlled foldamers in 
bilayers (Supplementary Fig. 5.1) whereas the CD titration of Cu-3 in bilayers 
with L-2a, which gave a positive signal at 239 nm (Supplementary Fig. 6.6.1), 
showed that the induction of screw sense at the BQPA binding site occurred with 
the same sense as in solution (Fig. 2f). Since opposite enantiomers of 2a still 
induced opposite responses in Cu-1 (L-2a decreasing and D-2a increasing the 
excimer emission intensity and the E/M ratio), a generalised ligand-induced 
change in bilayer properties could be ruled out as the origin of the fluorescence 
modulation. Additionally, homologous foldamers with shorter Aib chains (Aib4 in 
place of Aib8) showed no fluorescent response, not only confirming that there is 
no direct interaction between ligand and fluorophore but also suggesting that 
higher hydrophobicity may promote deeper membrane insertion that is required 
for function. Fitting the changes in Cu-1 excimer emission to a 1:1 binding model 
confirmed that binding of these agonists to membrane-bound Cu-1 was 100-fold 
weaker than in CH3CN solution (L-2a gave Kd ≈ 140 µM; D-2a gave Kd ≈ 60 µM). 
The half maximal effective concentration (EC50) values, which are commonly 
used34 to quantify responses of membrane-bound receptors, were calculated by 
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fitting the changes in E/M. This provided EC50 = 130 ± 30 µM and 70 ± 30 µM for 
L-2a and D-2a respectively. 
It was not possible to assign with confidence the precise orientation of the 
foldamer in the bilayer. The ability of the polar carboxylate ions to enter the 
binding site implies this polar Cu(II)-bearing moiety is exposed to the aqueous 
environment surrounding the vesicles. Comparing the ratio of monomer 
emission intensities from the I and III emission bands from the pyrene 
fluorophore35 of Cu-1 in organic solvents to Cu-1 in a bilayer indicates that the 
pyrenes are in a polar environment to which water has access. This suggests that 
the pyrenes lie within the membrane but close to the interface with water, 
possibly on the other side of the bilayer (foldamers of similar length and 
structure are capable of spanning the bilayer19). 
Other carboxylates appeared to bind within the pocket, such as unprotected L-
proline (EC50 ~ 130 µM), but these agonists had lower efficacy and only induced 
very weak conformational responses in membrane-embedded Cu-1. Glutamate 
and aspartame induced no change in fluorescence, although another Boc-
protected amino acid, Boc-L-Leu L-2c, induced a decrease in E/M (EC50 = 40 ± 20 
µM), albeit more weakly than L-2a. Binding seemed to translate into a remote 
conformational response only with carboxylate ligands containing an amide-like 
carbonyl group, probably through hydrogen bonding to an adjacent Aib residue 
in the helical oligomer (see Fig. 1a and Supplementary Fig. 6.7.4). With this in 
mind, Leu-enkephalin (Tyr-Gly-Gly-Phe-Leu, 2d), an endogenous opioid peptide 
neurotransmitter that binds μ- and δ-opioid GPCRs,36 was tested. Remarkably we 
found that Leu-enkephalin (EC50 = 70 ± 30 µM) induced a powerful response in 
our receptor mimic, increasing E/M significantly. 
Carboxylate ligand binding to membrane-bound Cu-1 is reversible, and this 
feature was demonstrated using competitive binding between an “agonist” and 
an “antagonist”. Addition of the “agonist” Leu-enkephalin 2d resulted in an 
increase in E/M in Cu-1, which could be reversed and then inverted by 
competitive binding of the “antagonist” L-BocPro L-2a (Fig. 4c). Ligand L-2a thus 
behaves in a manner analogous to μ- and δ-opioid GPCR antagonists such as 
naloxone.37,38 
Conclusions.  
Designed synthetic molecules 1 are far simpler than biological receptors of the 
GPCR family, yet they display all the characteristics required of a functional, 
synthetic, ‘minimal’ receptor.  They embed themselves into a membrane, they 
exhibit selective and competitive binding of certain classes of ligand at a well-
defined binding site, they change conformation as a result of ligand binding, and 
the resulting conformational change is transmitted through the receptor to a site 
remote from the binding site.  Cu-1 and its congeners offer a rare opportunity to 
compare the conformational behaviour of a molecule in solution and in the 
membrane phase, and to probe the effect of the membrane on conformational 
preference and ligand binding. Receptor 1 is of a length comparable with the 
thickness of a typical cell membrane, and we are currently exploring the 
possibility of using its metal complexes to transmit chemical information 
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through a membrane barrier, with the aim of controlling functional behaviour in 
artificial vesicles, and ultimately even in living cells. 
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Summary for TOC: 
 
A dynamic foldamer scaffold borrowed from a class of membrane-active fungal 
antibiotics was ligated to a water-compatible, metal-centred binding site and a 
conformationally-responsive fluorophore, providing a receptor mimic that 
inserts into the membrane of artificial vesicles. The binding site selected for 
specific carboxylate ligands, which induced fluorimetrically-detectable global 
conformational changes that depended on the structure of the ligand. 
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Figure 1: Design and Function of a Synthetic GPCR mimic. The receptor mimic is built from 
three components: a metal-containing binding site (shown in green), a helical Aib oligomer 
(shown in black or grey) which allows the receptor to embed into the membrane and relays 
conformational changes from the binding site to the reporter, and a fluorophore (shown in blue) 
to provide a spectroscopic indicator of conformational change. a, Structure of a synthetic GPCR 
mimic 1 with copper(II) cofactor binding a carboxylate ligand (shown in red). b, Change in 
equilibrium population distribution of right and left-handed screw-sense conformers in response 
to reversible binding of a chiral carboxylate ligand (shown in red). 
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Figure 2: Ligand-induced conformational responses in solution. Binding of enantiomeric 
carboxylate ligands Boc-L-Pro (L-2a, shown in orange) or Boc-D-Pro (D-2a, shown in red) induce 
opposite effects at the remote fluorescent reporter through a conformational relay mechanism 
that involves an inversion of screw sense in the helical domain of the receptor. a, Structures of 
the chiral carboxylate ligands used in the study. b, Tight but reversible complexation of chiral 
ligand L-2a to receptor Cu-1 in organic solvent, inducing a change in the relative population of 
conformers of the fluorophore. c,d, Corresponding changes in the CD (c) and fluorescence (d) 
spectra of Cu-1 (10 M in acetonitrile) on addition of L-2a (direction of change shown by orange 
arrow) and D-2a (direction of change shown by redarrow). The CD spectrum (c) reports a local 
change in conformation at the binding site, while the fluorescence spectrum (d) reports a global 
change in conformation of the receptor, relayed to the remote fluorophore. e, Changes in the E/M 
ratio (outline markers) and ellipticity at 239 nm (solid markers) upon incremental addition of L-
2a (orange markers) and D-2a (red markers) to Cu-1. Curve fits shown for Kd = 1 µM (D-2a) and 
Kd = 1.7 µM (L-2a). f, Changes in CD spectra upon addition of L-2a (shown as a series of spectra, 
direction of change indicated by orange arrow, and plotted as orange points) and D-2a (plotted 
as red points) to modified receptor Cu-3 (0.25 mM), which contains a binding site (green) but no 
fluorescent reporter. g, Changes in E/M ratio upon addition of L-2a and D-2a to helical foldamer 
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4 (10 M in acetonitrile), which contains the fluorescent reporter (blue) but no binding site. The 
lack of response on addition to either L-2a (orange markers) or D-2a (red markers) indicates 
that the binding site is required for the remote induction of a fluorescent response. 
 
Figure 3: Incorporation of the receptor mimic into the membrane of artificial vesicles. The 
receptor mimic migrates from solution to the phospholipid bilayer of the vesicles to generate a 
stable, fluorescent membrane-embedded structure over a period of 1-2 h a, Schematic 
representation of Cu-1 inserting into the membranes of DOPC LUVs and becoming fluorescent. b, 
Change in fluorescence of Cu-1 over 2 h after addition to DOPC LUVs, showing in increase in both 
excimer (E) and monomer (M) emission. c, Change in E/M ratio in the fluorescence emission 
from Cu-1 after mixing with DOPC LUVs. In binding experiments, ligands were added after the 
E/M value had stabilised, in the period between 1 and 1.5 h after addition of the receptor to the 
vesicles, as indicated by dotted lines. d, Fluorescence microscopy image of DOPC LUVs after 
mixing with Cu-1, showing fluorescence localised in the vesicle membranes. Scale bar = 100 μm. 
  
12 
 
 
Figure 4: Ligand-induced conformational responses in the membrane phase. Adding 
carboxylate ligands to the membrane-embedded receptors induces characteristic conformational 
changes, detected as changes in the excimer to monomer (E/M) emission ratio. a, Suite of chiral 
ligands 2a – 2d screened against membrane-bound Cu-1 (10 M, 0.4 mol% loading in DOPC 
vesicles). b, Changes in the fluorescence spectra of membrane-bound Cu-1 after addition of 
ligands L-2a, D-2a, L-2b, L-2c, 2d, coloured as in a (EC50 values from curve fits: 144, 98, 138, 55, 
72 µM respectively). Indicated errors are the standard deviations of at least three sets of 
measured data. c, Switching between conformation populations of Cu-1 by addition of “agonist” 
Leu-enkephalin 2d (shown in purple, curve fit EC50 = 72 µM) then “antagonist” Boc-L-Pro L-2a 
(shown in orange, competition with 2d gives EC50 = 360 µM).  
 
 
